http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104211708-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D265-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-113 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-541 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-536 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04 |
| filingDate | 2013-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104211708-B |
| titleOfInvention | Benzoxazinone derivatives and its application as antiseptic |
| abstract | The invention discloses formula (I) benzoxazinone derivatives, its synthetic method and its as antiseptic in the infectious diseases caused by bacterium, the application especially in the pulmonary tuberculosis caused by mycobacteria (TB).Specifically, the present invention relates to the compound of formula (I), pharmaceutically acceptable salt and the pharmaceutical composition comprising the compounds of this invention, wherein R 1 ‑R 4 And X is as used in the description.The present invention is directed to prepare with the active noval chemical compound of anti-mycobacteria, it is as potential novel drugs, it can be used for the infectious diseases caused by bacterium, the especially treatment or prevention treatment of the pulmonary tuberculosis caused by mycobacteria (TB) disease, it can be used for overcoming the problems, such as simultaneously related with drug resistance, and on the basis of keeping tubercle bacillus resistant activity, improve pharmacokinetic properties. |
| priorityDate | 2013-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 264.